全文获取类型
收费全文 | 409篇 |
免费 | 26篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 31篇 |
妇产科学 | 7篇 |
基础医学 | 35篇 |
口腔科学 | 11篇 |
临床医学 | 52篇 |
内科学 | 73篇 |
皮肤病学 | 11篇 |
神经病学 | 32篇 |
特种医学 | 65篇 |
外科学 | 40篇 |
综合类 | 16篇 |
预防医学 | 20篇 |
眼科学 | 9篇 |
药学 | 17篇 |
1篇 | |
肿瘤学 | 14篇 |
出版年
2022年 | 3篇 |
2021年 | 4篇 |
2020年 | 8篇 |
2019年 | 4篇 |
2018年 | 7篇 |
2017年 | 4篇 |
2016年 | 13篇 |
2015年 | 15篇 |
2014年 | 8篇 |
2013年 | 13篇 |
2012年 | 22篇 |
2011年 | 12篇 |
2010年 | 14篇 |
2009年 | 19篇 |
2008年 | 24篇 |
2007年 | 20篇 |
2006年 | 19篇 |
2005年 | 18篇 |
2004年 | 16篇 |
2003年 | 17篇 |
2002年 | 18篇 |
2001年 | 6篇 |
2000年 | 8篇 |
1999年 | 4篇 |
1998年 | 8篇 |
1997年 | 21篇 |
1996年 | 8篇 |
1995年 | 10篇 |
1994年 | 11篇 |
1993年 | 7篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 6篇 |
1988年 | 11篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 5篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 4篇 |
1981年 | 6篇 |
1977年 | 8篇 |
1976年 | 4篇 |
1974年 | 2篇 |
1970年 | 1篇 |
1966年 | 1篇 |
1964年 | 2篇 |
1963年 | 1篇 |
1943年 | 1篇 |
排序方式: 共有435条查询结果,搜索用时 22 毫秒
101.
102.
Nicola?S?Oldham Nat?MJ?WrightEmail author Clive?E?Adams Laura?Sheard Charlotte?NE?Tompkins 《BMC family practice》2004,5(1):9
Background
Heroin is a synthetic opioid with an extensive illicit market leading to large numbers of people becoming addicted. Heroin users often present to community treatment services requesting detoxification and in the UK various agents are used to control symptoms of withdrawal. Dissatisfaction with methadone detoxification [8] has lead to the use of clonidine, lofexidine, buprenorphine and dihydrocodeine; however, there remains limited evaluative research. In Leeds, a city of 700,000 people in the North of England, dihydrocodeine is the detoxification agent of choice. Sublingual buprenorphine, however, is being introduced. The comparative value of these two drugs for helping people successfully and comfortably withdraw from heroin has never been compared in a randomised trial. Additionally, there is a paucity of research evaluating interventions among drug users in the primary care setting. This study seeks to address this by randomising drug users presenting in primary care to receive either dihydrocodeine or buprenorphine.Methods/design
The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project is a pragmatic randomised trial which will compare the open use of buprenorphine with dihydrocodeine for illicit opiate detoxification, in the UK primary care setting. The LEEDS project will involve consenting adults and will be run in specialist general practice surgeries throughout Leeds. The primary outcome will be the results of a urine opiate screening at the end of the detoxification regimen. Adverse effects and limited data to three and six months will be acquired.103.
104.
The role of oxygen-derived free radicals has been suggested in genesis of epilepsy and in the post seizure neuronal death. The aim of this study was to investigate whether erdosteine has a preventive effect against epilepsy and postepileptic oxidative stress. The mice (n=27) were divided into three groups: (i) PTZ-induced-epilepsy group (n=9); (ii) PTZ-induced-epilepsy+erdosteine group (n=9); (iii) control group (n=9). The animals were observed for a period of 30 min for latency to first seizure onset, total seizure duration, the number of seizure episodes. Then they were sacrificed and the brains were quickly removed, and frozen for biochemical analysis. Malondialdehyde (MDA), nitric oxide (NO), superoxide dismutase (SOD) and xanthine oxidase (XO) activities were carried out in the brain tissue. The latent period between PTZ induction and seizure are longer in the PTZ+erdosteine group than in PTZ-induced-epilepsy group (P<0.05). Biochemical analyses of brain tissue, revealed a significant increase in the MDA, XO and NO levels in the PTZ group according to erdosteine group. SOD level did not change in this group. While MDA and XO levels are significantly lower, SOD level is significantly higher in the PTZ+erdosteine group compared to PTZ and control groups (P<0.01). The present study demonstrated that erdosteine treatment both may increase latent interval between seizures and may decrease oxidative stress, thus may ameliorate neuronal death in brain during seizures. It may be used as an adjunct therapy in epilepsy. 相似文献
105.
Endovascular coil embolization of residual or recurrent aneurysms after surgical clipping 总被引:2,自引:0,他引:2
Cekirge HS Islak C Firat MM Kocer N Saatci I 《Acta radiologica (Stockholm, Sweden : 1987)》2000,41(2):111-115
Purpose: Treatment of residual or recurrent aneurysms after surgical clipping is a challenge and most surgeons prefer to avoid a second surgical attempt. We present treatment of 4 residual or recurrent aneurysms after surgical clipping with electrolytically detachable coils.Material and Methods: In 3 of 4 patients, recurrent aneurysms were diagnosed with angiography 2 months, 5 years and 14 years after surgery, although the domes of the aneurysms were opened following clipping during the surgery. In the 4th patient, an early postoperative angiogram revealed filling of a residual aneurysm secondary to the incomplete neck clipping. Guglielmi detachable coils were used to occlude the residual or recurrent aneurysm.Results: The endovascular approach was successful in all patients and the control angiograms showed complete obliteration of the aneurysms with no recanalization.Conclusion: The endovascular approach is a good treatment option for patients in whom complete obliteration of the aneurysm cannot be achieved by surgical clipping. Opening of the aneurysm sac after clipping does not necessarily preclude aneurysm regrowth from a neck remnant proximal to the clip. 相似文献
106.
目的:研究父母的母语为非英语的婴儿比父母的母语为英语的婴儿是否更不易接受推荐的预防性医疗行为。研究设计:笔者对1999年1月1日至2000年9月30日期间在华盛顿州出生的所有38793例参加医疗救助的1岁婴儿进行回顾性组群研究。主要因素为自己报告的父母的母语。笔者使用多参数回 相似文献
107.
Kizilkilic O Albayram S Adaletli I Kantarci F Uzma O Islak C Kocer N 《Archives of gynecology and obstetrics》2003,268(4):325-328
Subarachnoid hemorrhage from an intracranial aneurysm during pregnancy is a rare complication with high maternal and fetal
morbidity-mortality. We report three cases of ruptured intracranial aneurysms during pregnancy, treated by the minimal invasive
endovascular approach. 相似文献
108.
Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Lethal toxin, produced by the bacterium Bacillus anthracis, is a major contributor to morbidity and mortality in animals and humans who have contracted anthrax. One component of this toxin, lethal factor (LF), proteolytically inactivates members of the mitogen-activated protein kinase kinase (MAPKK or MEK) family. In this study we show that CMT-300, CMT-308, and Ilomastat, agents initially characterized as matrix metalloproteinase inhibitors which are in early stages of development as pharmaceuticals, effectively inhibit the zinc metalloproteinase activity of LF. All three inhibitors, CMT-300, CMT-308, and Ilomastat, inhibit LF-mediated cleavage of a synthetic peptide substrate based on the N-terminal domain of MEKs. Inhibition of LF-mediated MEK proteolysis by all three agents was also achieved using lysates of the human monocytoid line MonoMac 6 as sources of MAPKKs and visualization of the extent of cleavage after separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by detection by Western blotting. Finally, we have demonstrated inhibition of intracellular MEKs in viable human monocytes and MonoMac 6 cells by these agents after incubation of the cells with a reconstituted preparation of recombinant lethal toxin. All three agents are effective inhibitors when incubated with LF prior to exposure to cells, while the CMTs, but not Ilomastat, are also effective when added after LF has already entered the viable cell targets. These results offer promise for strategies to combat effects of the lethal toxin of B. anthracis. 相似文献
109.
Characterization of susceptible chiasma configurations that increase the risk for maternal nondisjunction of chromosome 21 总被引:17,自引:4,他引:17
Lamb NE; Feingold E; Savage A; Avramopoulos D; Freeman S; Gu Y; Hallberg A; Hersey J; Karadima G; Pettay D; Saker D; Shen J; Taft L; Mikkelsen M; Petersen MB; Hassold T; Sherman SL 《Human molecular genetics》1997,6(9):1391-1399
Recent studies of trisomy 21 have shown that altered levels of
recombination are associated with maternal non-disjunction occurring at
both meiosis I (MI) and meiosis II (MII). To comprehend better the
association of recombination with nondisjunction, an understanding of the
pattern of meiotic exchange, i.e. the exchange of genetic material at the
four-strand stage during prophase, is required. We examined this underlying
exchange pattern to determine if specific meiotic configurations are
associated with a higher risk of non-disjunction than others. We examined
the crossover frequencies of chromosome 21 for three populations: (i)
normal female meiotic events; (ii) meiotic events leading to MI
non-disjunction; and (iii) those leading to MII non-disjunction. From these
crossover frequencies, we estimated the array of meiotic tetrads that
produced the observed crossovers. Using this approach, we found that nearly
one-half of MI errors were estimated to be achiasmate. The majority of the
remaining MI bivalents had exchanges that clustered at the telomere. In
contrast, exchanges occurring among MII cases clustered at the
pericentromeric region of the chromosome. Unlike the single exchange
distributions, double exchanges from the non-disjoined populations seemed
to approximate the distribution in the normal population. These data
suggest that the location of certain exchanges makes a tetrad susceptible
to non- disjunction. Specifically, this susceptibility is associated with
the distance between the centromere and closest exchange. This result
challenges the widely held concept that events occurring at MII are largely
independent of events occurring at MI, and suggests that all
non-disjunction events may be initiated during MI and simply resolved at
either of the two meiotic stages.
相似文献
110.
Kiewe P; Bechrakis NE; Schmittel A; Ruf P; Lindhofer H; Thiel E; Nagorsen D 《Annals of oncology》2006,17(12):1830-1834
Background: Metastatic uveal melanoma has a poor prognosis andlimited therapeutic options. Proteoglycans are involved in tumorcell invasion and metastatic behavior. The mAbB5 stains a chondroitinsulphate proteoglycan (CSPG) on cutaneous melanoma cells. Here,we compare the B5-staining of CSPG in primaries and metastasesof uveal melanoma. Material and methods: Immunohistopathological staining was performedin 15 cutaneous and 39 uveal melanoma samples. A score for intracellularand surface staining was established. B5 staining was comparedin primaries and metastases of uveal melanoma using Student'st-test. Results: Eight of 11 (73%) uveal melanoma metastases were positivefor B5-staining whereas only 5 of 28 (18%) primary uveal melanomasamples were B5-positive (P < 0.001). Nine of 15 cutaneousmelanoma samples (60%) were B5-positive without significantdifference between primary and metastatic lesions. Surface stainingwas found both on uveal melanoma metastases and cutaneous melanomas. Conclusions: CSPG was expressed significantly more often inmetastases than in primaries of uveal melanoma. It potentiallymay be one factor associated with metastatic spread. Furtherstudies are needed to determine its use as prognostic factor.The mAbB5 may also be a promising tool for immunotherapy dueto its strong staining of CSPG on the surface of cutaneous andmetastatic uveal melanoma cells. Key words: uveal melanoma, ocular melanoma, chondroitin sulphate proteoglycan, immunotherapy, immunohistochemistry 相似文献